Status:
COMPLETED
Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Hyperglycemia
Diabetes
Eligibility:
All Genders
50+ years
Brief Summary
To determine whether intraoperative hyperglycemia potentiates renal injury in the setting of cardiac surgery requiring cardiopulmonary bypass.
Detailed Description
Significance: Postoperative renal dysfunction is a common complication of cardiopulmonary bypass occurring in nearly 8% of all patients undergoing myocardial revascularization. Both diabetes and preo...
Eligibility Criteria
Inclusion
- Male and female patients ≥ 50 years of age
- Patients undergoing on pump cardiopulmonary bypass for either myocardial revascularization (coronary artery bypass graft) or valvular surgery (valve repair or replacement)
Exclusion
- Patients with insulin dependent diabetes
- Patients with preexisting renal dysfunction defined as Creatinine\> 2 mg/dl
- Patients in need of emergency cardiac procedures
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00404950
Start Date
July 1 2005
End Date
July 1 2012
Last Update
February 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The New York Presbyterian Hospital - Weill Medical College of Cornell University
New York, New York, United States, 10021